Latest News on CBLL

Latest News on CBLL

Financial News Based On Company

Want to find fair value of CBLL?

Advertisement

Advertisement

CeriBell ( CBLL ) Q2 Revenue Jumps 38%

https://www.fool.com/data-news/2025/08/06/ceribell-cbll-q2-revenue-jumps-38/

CeriBell ( NASDAQ:CBLL ) , the neurotechnology company specializing in rapid electroencephalography ( EEG ) and artificial intelligence for seizure detection, announced its results for Q2 2025 on August 5, 2025. The company's revenue ( GAAP ) reached $21.2 million, up from $15.3 million in Q2 ...

Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware

https://www.globenewswire.com/news-release/2025/07/07/3111338/0/en/Ceribell-Files-Complaints-Against-Natus-Medical-Incorporated-with-the-U-S-International-Trade-Commission-and-Federal-Court-in-Delaware.html

Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography ( EEG ) Technology Complaints Assert Infringement of Patents Related to Point-of-Care Electroencephalography ( EEG ) Technology ...

Ceribell to Participate in the William Blair 45th Annual Growth Stock Conference - CeriBell ( NASDAQ:CBLL )

https://www.benzinga.com/pressreleases/25/05/g45529255/ceribell-to-participate-in-the-william-blair-45th-annual-growth-stock-conference

SUNNYVALE, Calif., May 20, 2025 ( GLOBE NEWSWIRE ) -- CeriBell, Inc. CBLL ( "Ceribell" ) , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at ...

CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm

https://www.zacks.com/stock/news/2450012/cbll-stock-falls-despite-fda-clearance-for-pediatric-clarity-algorithm

Ceribell secures FDA clearance for Clarity algorithm in pediatric patients, expanding rapid seizure detection capabilities and enhancing critical care efficiency.

Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday - Amarin Corp ( NASDAQ:AMRN ) , Absci ( NASDAQ:ABSI )

https://www.benzinga.com/25/04/44763680/fastenal-posts-better-than-expected-sales-joins-simulations-plus-certara-and-other-big-stocks-moving-higher-on-fr

U.S. stocks were lower, with the Dow Jones index dipping over 250 points on Friday. Shares of Fastenal Company FAST rose sharply during Thursday's session following better-than-expected first-quarter sales.

Advertisement

This Lattice Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - CeriBell ( NASDAQ:CBLL ) , Lattice Semiconductor ( NASDAQ:LSCC )

https://www.benzinga.com/25/04/44645601/this-lattice-semiconductor-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Loop Capital initiated coverage on Lattice Semiconductor Corporation LSCC with a Buy rating ...

Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer

https://www.benzinga.com/pressreleases/25/03/g44454535/kevin-kearney-joins-lungpacer-medical-as-chief-commercial-officer

EXTON, Pa., March 24, 2025 ( GLOBE NEWSWIRE ) -- Lungpacer Medical today announced the appointment of Kevin Kearney as Chief Commercial Officer ( CCO ) . Kearney brings over 20 years of commercial leadership, business development, and strategic sales operations experience in the medical device ...

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

https://www.globenewswire.com/news-release/2024/12/23/3001485/0/en/Ceribell-to-Participate-in-the-43rd-Annual-J-P-Morgan-Healthcare-Conference.html

SUNNYVALE, Calif., Dec. 23, 2024 ( GLOBE NEWSWIRE ) -- Ceribell, Inc. ( Nasdaq: CBLL ) ( "Ceribell" ) , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, ...

Ceribell to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - CeriBell ( NASDAQ:CBLL )

https://www.benzinga.com/pressreleases/24/12/g42660856/ceribell-to-participate-in-the-43rd-annual-j-p-morgan-healthcare-conference

SUNNYVALE, Calif., Dec. 23, 2024 ( GLOBE NEWSWIRE ) -- Ceribell, Inc. CBLL ( "Ceribell" ) , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present ...

Nasdaq Welcomed 171 IPOs in 2024

https://www.globenewswire.com/news-release/2024/12/17/2998234/6948/en/Nasdaq-Welcomed-171-IPOs-in-2024.html

Leading U.S. exchange by number of IPOs and proceeds raised for the sixth consecutive year ...

Advertisement

Nasdaq Welcomed 171 IPOs in 2024 - Nasdaq ( NASDAQ:NDAQ )

https://www.benzinga.com/pressreleases/24/12/g42528285/nasdaq-welcomed-171-ipos-in-2024

NEW YORK, Dec. 17, 2024 ( GLOBE NEWSWIRE ) -- Nasdaq NDAQ announced today that in 2024, it welcomed 171 initial public offerings ( IPOs ) , raising a total of $22.7 billion.

Ceribell Receives Authority to Operate from the U.S. Department of Veterans Affairs - CeriBell ( NASDAQ:CBLL )

https://www.benzinga.com/pressreleases/24/11/g41876652/ceribell-receives-authority-to-operate-from-the-u-s-department-of-veterans-affairs

-Ceribell System stands to reduce costly ICU admissions and intra-facility patient transfers- -Military veterans face elevated risks of developing seizure disorders- SUNNYVALE, Calif., Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- CeriBell, Inc.

This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Eaton Corp ( NYSE:ETN )

https://www.benzinga.com/news/24/11/41743044/this-eaton-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Barclays analyst George Wang initiated coverage on Celestica Inc.

Advertisement

Advertisement

This website offers free financial information to empower your financial decisions.

We’re committed to keeping our financial tools free for everyone. If you’ve found value here, a small donation helps us stay independent and continue growing. Thank you for your support!

❤️ Support Our Mission - Keep Our Tools Free! ❤️

Most companies charge $50 to $100 per month for tools like ours. That’s roughly $2,000 to $3,000 per year spent on various subscriptions.

We’ve chosen to make these powerful financial tools available to you completely free.

If you’ve found value here, please consider making a small donation.
Your support helps us stay free and continue growing!

Thank you for supporting our work! 🙏

Disclaimer

The Value-Trades website is intended for informational purposes only. The content provided on this website, including but not limited to recommendations, analysis, and opinions, should not be considered financial advice. Before making any investment decisions, whether buying or selling, based on information obtained from this website, it is imperative that you conduct your own thorough due diligence. This includes consulting with a qualified financial advisor, reviewing financial statements, and understanding the risks involved in any investment. The owner of this website shall not be held responsible for any financial losses incurred as a result of using the information provided herein. Investing in financial markets involves risk, and past performance is not indicative of future results. You are solely responsible for your investment decisions.

© 2025 Value-Trades